Mesenchymal stem cells (MSCs), the major stem cells for cell therapy, have been used in
the clinic for approximately 10 years. From animal models to clinical trials, MSCs have …

Mesenchymal stem/stromal cells (MSCs) comprise a heterogeneous population of cells with
multilineage differentiation potential, the ability to modulate oxidative stress, and secrete …

The potential use of stem cell‐based therapies for the repair and regeneration of various
tissues and organs offers a paradigm shift that may provide alternative therapeutic solutions …

Aside from the well-established self-renewal and multipotent differentiation properties,
mesenchymal stem cells exhibit both immunomodulatory and anti-inflammatory roles in …

Mesenchymal stem cells (MSCs) have great potential for treating various diseases,
especially those related to tissue damage involving immune reactions. Various studies have …

Extracellular vesicles (EVs, including exosomes) are implicated in many aspects of nervous
system development and function, including regulation of synaptic communication, synaptic …

In 2002, researchers at UCLA published a manuscript in Molecular Biology of the Cell
describing a novel adult stem cell population isolated from adipose tissue—the adipose …

Background aims. Transplantation of mesenchymal stromal cells (MSC) derived from bone
marrow (BM) or adipose tissue is expected to become a cell therapy for stroke. The present …

In 2001, researchers at the University of California, Los Angeles, described the isolation of a
new population of adult stem cells from liposuctioned adipose tissue. These stem cells, now …

Adipose tissue is now recognized as an accessible, abundant, and reliable site for the
isolation of adult stem cells suitable for tissue engineering and regenerative medicine …